| Name | Title | Contact Details |
|---|
Bhrigus Inc is a North Brunswick, NJ-based company in the Computers and Electronics sector.
Infoblox delivers essential technology to help customers control their networks. Our patented Grid™ technology helps businesses automate complex network control functions to reduce costs and increase security and uptime. Infoblox is a global company, with operations in 25 countries. Our solutions help over 7,900 enterprises and service providers make their networks more available, secure and automated.
Permessa Corp is a Waltham, MA-based company in the Computers and Electronics sector.
CognitiveScale was founded in 2013 by highly successful serial entrepreneurs and senior executives with deep expertise in vertical enterprise software, cloud computing, and machine learning. The company has won numerous awards and featured in prominent research and publications. It is headquartered in Austin, Texas, with offices in the United Kingdom and India, and has strategic partnerships with IBM and Deloitte.
IdentifySensors is a leading developer of digital diagnostic technologies on graphene-based biosensors. The company is principally focused on developing real-time pathogen detection capabilities for direct diagnosis and remote monitoring. The company`s technology has expanded into multiple industries and applications, such as pathogen diagnostics and testing for food contamination. Check4® by IdentifySensors Biologics® is a next-generation digital diagnostic platform intended to detect multiple pathogens within 5 minutes at the molecular gene level. The platform is intended to eliminates the need for enzymatic amplification and reagents. Graphene sensor technology has moved diagnostics beyond chemical testing into a rapid digital platform intended to be as accurate as a PCR test but significantly more sensitive and cost effective. Printed graphene sensors isolate targeted viruses and bacteria from saliva and other bodily fluids within a handheld, Bluetooth device. The platform is intended to detect the genetic material of dozens of pathogens for over-the-counter and point-of-care use. With a target price at a fraction of current molecular tests, Check4® is intended to disrupt the PCR market for many infections. The Check4® testing platform comes is two main parts: 1) A reader, which connects to a user`s cell phone or to a clinical database; and 2) Single-use test cartridges, which can contain multiple graphene sensors to detect multiple infections. The reader, which can be reused thousands of times, serves as the base of the platform, accepting any number of test cartridges. Disposable test cartridges, which require the reader to work, will be sold separately.